Literature DB >> 26109426

Selective cell targeting and lineage tracing of human induced pluripotent stem cells using recombinant avian retroviruses.

Laura Hildebrand1,2, Petra Seemann1,2, Andreas Kurtz1,2,3, Jochen Hecht1,2,4, Jörg Contzen2,5, Manfred Gossen2,5, Harald Stachelscheid6,7,8.   

Abstract

Human induced pluripotent stem cells (hiPSC) differentiate into multiple cell types. Selective cell targeting is often needed for analyzing gene function by overexpressing proteins in a distinct population of hiPSC-derived cell types and for monitoring cell fate in response to stimuli. However, to date, this has not been possible, as commonly used viruses enter the hiPSC via ubiquitously expressed receptors. Here, we report for the first time the application of a heterologous avian receptor, the tumor virus receptor A (TVA), to selectively transduce TVA(+) cells in a mixed cell population. Expression of the TVA surface receptor via genetic engineering renders cells susceptible for infection by avian leucosis virus (ALV). We generated hiPSC lines with this stably integrated, ectopic TVA receptor gene that expressed the receptor while retaining pluripotency. The undifferentiated hiPSC(TVA+) as well as their differentiating progeny could be infected by recombinant ALV (so-called RCAS virus) with high efficiency. Due to incomplete receptor blocking, even sequential infection of differentiating or undifferentiated TVA(+) cells was possible. In conclusion, the TVA/RCAS system provides an efficient and gentle gene transfer system for hiPSC and extends our possibilities for selective cell targeting and lineage tracing studies.

Entities:  

Keywords:  ALV; Induced pluripotent stem cells; Lineage tracing; Selective cell targeting; TVA

Mesh:

Substances:

Year:  2015        PMID: 26109426     DOI: 10.1007/s00018-015-1957-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

Review 1.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

Review 2.  Manipulating gene expression with replication-competent retroviruses.

Authors:  B A Morgan; D M Fekete
Journal:  Methods Cell Biol       Date:  1996       Impact factor: 1.441

Review 3.  Induced pluripotent stem cells and their implication for regenerative medicine.

Authors:  Maria Csobonyeiova; Stefan Polak; Jan Koller; Lubos Danisovic
Journal:  Cell Tissue Bank       Date:  2014-07-19       Impact factor: 1.522

4.  Acquisition of Host Cell DNA Sequences by Baculoviruses: Relationship Between Host DNA Insertions and FP Mutants of Autographa californica and Galleria mellonella Nuclear Polyhedrosis Viruses.

Authors:  M J Fraser; G E Smith; M D Summers
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

5.  Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system.

Authors:  Alexander von Werder; Barbara Seidler; Roland M Schmid; Günter Schneider; Dieter Saur
Journal:  Nat Protoc       Date:  2012-05-24       Impact factor: 13.491

6.  Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector.

Authors:  B C Lewis; N Chinnasamy; R A Morgan; H E Varmus
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Splinkerette PCR for mapping transposable elements in Drosophila.

Authors:  Christopher J Potter; Liqun Luo
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  A novel Flk1-TVA transgenic mouse model for gene delivery to angiogenic vasculature.

Authors:  Virginie S Vervoort; Mark Lu; Fatima Valencia; Jacqueline Lesperance; Georg Breier; Robert Oshima; Elena B Pasquale
Journal:  Transgenic Res       Date:  2007-11-20       Impact factor: 2.788

Review 9.  The RCAS vector system.

Authors:  Stephen H Hughes
Journal:  Folia Biol (Praha)       Date:  2004       Impact factor: 0.906

10.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Authors:  Noemi Fusaki; Hiroshi Ban; Akiyo Nishiyama; Koichi Saeki; Mamoru Hasegawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

View more
  1 in total

Review 1.  Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.

Authors:  Arquimedes Cheffer; Lea Jessica Flitsch; Tamara Krutenko; Pascal Röderer; Liubov Sokhranyaeva; Vira Iefremova; Mohamad Hajo; Michael Peitz; Martin Karl Schwarz; Oliver Brüstle
Journal:  Mol Autism       Date:  2020-12-11       Impact factor: 7.509

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.